Axon Therapies

New York, NY · Founded 2014 · Privately Held (backing)

Developer of a healthcare device designed to reduce sympathetic nerve activity and address the root cause of heart failure. Axon Therapies is based in New York, NY and was founded in 2014. It was valued at $44.5 million at its later-stage round in Jan 2021, the last priced event on record. It has raised $75.8 million across 3 recorded rounds; the latest was a $7.5 million early-stage round in Jan 2019.

PMV mark · valuation
$44.5M
Oct 2026
Priced at
its later-stage round
Jan 2021
Total raised
$75.8M
Last round
Early Stage VC
Jan 2019

Who backs Axon Therapies?

7 investors
InvestorType
Earlybird Venture CapitalVenture capital
Deerfield ManagementVenture capital
CDBI PartnersOther
Action Potential Venture Capital—
Coridea—
KOFA Healthcare—
Santé Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Axon Therapies investors

7 investors are on record for Axon Therapies, including Earlybird Venture Capital, Deerfield Management, CDBI Partners and Action Potential Venture Capital. The early-stage round in Jan 2019 drew 10 investors.

Free account
More of Axon Therapies with a free account
  • ·Watch Axon Therapies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Axon Therapies. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View